The aim of this review is to present new data on epidermodysplasia verruciformis (EV) and
EV human papillomaviruses (HPVs), regarded previously as specific to the disease …

In a very interesting and provocative article, Antonsson et al. reported a high prevalence of
known or as-yet-uncharacterized human papillomavirus (HPV) genotypes on the healthy …

Recent polymerase chain reaction data have shown that most human papillomavirus (HPV)
genotypes associated with epidermodysplasia verruciformis (EV) are widespread; however …

We have shown previously in psoriasis a very high prevalence of epidermodysplasia
verruciformis‐associated human papillomavirus 5 (EVHPV5) DNA and antibodies to human …

The first evidence for the oncogenic potential of human papillomaviruses (HPVs) was
obtained through the study of epidermodysplasia verruciformis (EV). This rare skin disease …

Non-melanoma skin cancers (NMSC), namely basal cell carcinomas (BCC) and squamous
cell carcinomas (SCC), represent the most common form of malignancy in fairskinned …

Although a rare disease, epidermodysplasia verruciformis (EV) has played an important role
in showing that viruses may induce human cancer. Among the 24 human papillomaviruses …

Background Psoriasis is a T‐cell‐mediated immunological disease characterized by
epidermal proliferation. The nature of the antigen (s) responsible for T‐cell activation is still …

Epidermodysplasia verruciformis (EV) is a rare disease, characterized by cutaneous warts
and associated with a strong predisposition to β-genus human papillomavirus (HPV). Earlier …

Epidermodysplasia verruciformis (EV) is a rare genodermatosis characterized by an
abnormal susceptibility to infection with a specific group of related human papillomavirus …